Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Not Confirmed
Not Confirmed
03-05 September, 2025
Not Confirmed
Not Confirmed
04-06 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Industry Trade Show
Not Confirmed
03-05 September, 2025
Industry Trade Show
Not Confirmed
04-06 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
19 Aug 2025
// PRESS RELEASE
https://www.skyhawktx.com/post/skyhawk-therapeutics-announces-strategic-collaboration-with-merck-kgaa-darmstadt-germany-to-discov
17 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/skyhawk-therapeutics-announces-first-patient-dosed-in-phase-23-falcon-hd-trial-of-sky-0515-for-huntingtons-disease-302483907.html
09 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/skyhawk-therapeutics-receives-australian-regulatory-approval-to-extend-sky-0515-treatment-duration-in-phase-1-huntingtons-disease-patient-trial-302326386.html
24 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/skyhawk-therapeutics-presents-compelling-preclinical-data-on-sky-1214-at-the-eortc-nci-aacr-molecular-targets-and-cancer-therapeutics-symposium-302285986.html
11 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/skyhawk-therapeutics-to-present-additional-positive-topline-data-from-parts-a-and-b-of-phase-1-clinical-trial-of-sky-0515-at-european-huntingtons-disease-network-and-enroll-hd-2024-302244451.html
10 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/10/2911098/0/en/Skyhawk-Therapeutics-Announces-Positive-Topline-Results-from-Parts-A-and-B-of-its-Phase-1-Clinical-Trial-of-SKY-0515-as-a-Treatment-for-Huntington-s-Disease-Reaching-72-Huntingtin-.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE